KR101737656B1 - 당뇨병의 예방을 위한 설폰아마이드 - Google Patents

당뇨병의 예방을 위한 설폰아마이드 Download PDF

Info

Publication number
KR101737656B1
KR101737656B1 KR1020127010733A KR20127010733A KR101737656B1 KR 101737656 B1 KR101737656 B1 KR 101737656B1 KR 1020127010733 A KR1020127010733 A KR 1020127010733A KR 20127010733 A KR20127010733 A KR 20127010733A KR 101737656 B1 KR101737656 B1 KR 101737656B1
Authority
KR
South Korea
Prior art keywords
diabetes
days
meraxin
reparixin
stz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127010733A
Other languages
English (en)
Korean (ko)
Other versions
KR20120083889A (ko
Inventor
로렌조 피에몬티
루이사 다폰치오
마르셀로 알레그레티
Original Assignee
돔페 파르마써티씨 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 돔페 파르마써티씨 에스.피.에이. filed Critical 돔페 파르마써티씨 에스.피.에이.
Publication of KR20120083889A publication Critical patent/KR20120083889A/ko
Application granted granted Critical
Publication of KR101737656B1 publication Critical patent/KR101737656B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1020127010733A 2009-10-06 2010-10-06 당뇨병의 예방을 위한 설폰아마이드 Active KR101737656B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09172365.0 2009-10-06
EP09172365A EP2308485A1 (en) 2009-10-06 2009-10-06 Sulfonamides for the prevention of diabetes
PCT/EP2010/064920 WO2011042465A1 (en) 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes

Publications (2)

Publication Number Publication Date
KR20120083889A KR20120083889A (ko) 2012-07-26
KR101737656B1 true KR101737656B1 (ko) 2017-05-18

Family

ID=41716341

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127010733A Active KR101737656B1 (ko) 2009-10-06 2010-10-06 당뇨병의 예방을 위한 설폰아마이드

Country Status (24)

Country Link
US (2) US8846755B2 (https=)
EP (2) EP2308485A1 (https=)
JP (1) JP5745526B2 (https=)
KR (1) KR101737656B1 (https=)
CN (1) CN102639128B (https=)
AU (1) AU2010305384B2 (https=)
BR (1) BR112012007989B1 (https=)
CA (1) CA2776021C (https=)
CY (1) CY1117599T1 (https=)
DK (1) DK2485724T3 (https=)
EA (1) EA021788B1 (https=)
ES (1) ES2570463T3 (https=)
HR (1) HRP20160399T1 (https=)
HU (1) HUE028132T2 (https=)
IL (1) IL219038A (https=)
ME (1) ME02385B (https=)
MX (1) MX2012004087A (https=)
NZ (1) NZ599171A (https=)
PL (1) PL2485724T3 (https=)
RS (1) RS54693B1 (https=)
SI (1) SI2485724T1 (https=)
SM (1) SMT201600126B (https=)
WO (1) WO2011042465A1 (https=)
ZA (1) ZA201202462B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9844528B2 (en) * 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP3281937A1 (en) * 2016-08-09 2018-02-14 Dompé farmaceutici S.p.A. Sulfonamides as gpr40- and gpr120-agonists
US11291641B2 (en) 2016-10-03 2022-04-05 The Children's Medical Center Corporation Prevention and treatment of diabetic nephropathy
EP4686469A1 (en) 2024-07-31 2026-02-04 Dompé farmaceutici SpA Cxcl8 inhibitors for use in the treatment of diabetes-associated comorbidities

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009117710A2 (en) 2008-03-20 2009-09-24 Carolus Therapeutics, Inc. Methods of treating inflammation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
US20040242498A1 (en) * 2003-02-27 2004-12-02 Collins Tassie L. CXCR3 antagonists
ATE444286T1 (de) 2004-03-23 2009-10-15 Dompe Pha R Ma Spa Res & Mfg 2-phenylpropionsäurederivate und diese enthaltende pharmazeutische zusammensetzung
PT1579859E (pt) 2004-03-25 2007-03-30 Dompe Pha R Ma Spa Res & Mfg Utilização de n-(2-aril-propionil)-sulfonamidas pata o tratamento de lesões da medula espinal
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009117710A2 (en) 2008-03-20 2009-09-24 Carolus Therapeutics, Inc. Methods of treating inflammation

Also Published As

Publication number Publication date
IL219038A (en) 2015-07-30
NZ599171A (en) 2014-03-28
HRP20160399T1 (hr) 2016-05-20
US8846755B2 (en) 2014-09-30
AU2010305384B2 (en) 2016-02-04
CN102639128A (zh) 2012-08-15
IL219038A0 (en) 2012-06-28
JP5745526B2 (ja) 2015-07-08
HUE028132T2 (en) 2016-11-28
KR20120083889A (ko) 2012-07-26
CY1117599T1 (el) 2017-04-26
US20130059908A1 (en) 2013-03-07
JP2013506703A (ja) 2013-02-28
DK2485724T3 (en) 2016-05-02
EA021788B1 (ru) 2015-08-31
PL2485724T3 (pl) 2016-07-29
CA2776021C (en) 2017-08-01
BR112012007989B1 (pt) 2019-10-22
US9556115B2 (en) 2017-01-31
WO2011042465A1 (en) 2011-04-14
US20150011639A1 (en) 2015-01-08
ZA201202462B (en) 2013-06-26
AU2010305384A1 (en) 2012-04-26
RS54693B1 (sr) 2016-08-31
HK1174557A1 (en) 2013-06-14
EP2485724B1 (en) 2016-02-10
CA2776021A1 (en) 2011-04-14
SMT201600126B (it) 2016-07-01
ME02385B (me) 2016-09-20
EA201270512A1 (ru) 2012-11-30
SI2485724T1 (sl) 2018-12-31
MX2012004087A (es) 2012-08-23
ES2570463T3 (es) 2016-05-18
EP2308485A1 (en) 2011-04-13
CN102639128B (zh) 2014-02-26
EP2485724A1 (en) 2012-08-15

Similar Documents

Publication Publication Date Title
EP2579879B1 (en) Triazine derivatives for delaying the onset of type 1 diabetes
KR101737656B1 (ko) 당뇨병의 예방을 위한 설폰아마이드
KR20130083895A (ko) 2형 당뇨병의 치료
EA015382B1 (ru) Применение рофлумиласта для лечения сахарного диабета типа 2
KR20150046125A (ko) Sglt2 저해약과 항고혈압약의 조합
EP2763673A1 (en) Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury
US20120202884A1 (en) Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
CN108703946A (zh) 一种治疗糖尿病周围神经痛的透皮吸收制剂
CN110290788A (zh) 氨基甲酸酯化合物用于预防、缓解或治疗双相障碍的用途
JP7344422B2 (ja) 糖尿病予防・治療用の医薬品組成物及びその用途
HK1174557B (en) Sulfonamides for the prevention of diabetes
CN111067910B (zh) 一种用于预防和治疗糖尿病的药物组合物及其应用
CN114984005B (zh) 硫酸舒欣啶在制备抗肾功能衰竭药物中的应用
JP3713271B6 (ja) ３，５−ジアミノ−６−（２，３−ジクロロフェニル）−１，２，４−トリアジンの浮腫および痛みの治療のための使用
JP3713271B2 (ja) ３，５−ジアミノ−６−（２，３−ジクロロフェニル）−１，２，４−トリアジンの浮腫および痛みの治療のための使用
CN120227381A (zh) 依普利酮在制备治疗1型糖尿病的药物中的应用
Huang et al. Rhabdomyolysis after liver transplantation: a case report
CN120960416A (zh) 用于治疗糖尿病神经痛的药物组合物及其应用
JP2008525314A (ja) 胃不全麻痺様症状の治療及び／又は予防剤
HK40015213A (en) Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
HK1059213B (en) Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20120426

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20150826

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20151002

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20161111

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20170315

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20170512

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20170512

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20200429

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20200429

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20210430

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20210430

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20220428

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20220428

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20230426

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20240425

Start annual number: 8

End annual number: 8